PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,582,000 | -22.0% | 217,752 | -14.5% | 0.18% | -27.4% |
| Q2 2022 | $14,852,000 | -43.0% | 254,747 | -25.3% | 0.24% | -24.7% |
| Q1 2022 | $26,040,000 | +257.7% | 341,200 | +181.8% | 0.32% | +114.8% |
| Q3 2020 | $7,279,000 | +99.2% | 121,069 | +154.4% | 0.15% | +21.1% |
| Q4 2015 | $3,655,000 | +592.2% | 47,599 | +270.6% | 0.12% | +547.4% |
| Q3 2015 | $528,000 | -44.8% | 12,844 | -5.1% | 0.02% | -42.4% |
| Q2 2015 | $957,000 | -80.2% | 13,532 | -75.1% | 0.03% | -80.4% |
| Q1 2015 | $4,836,000 | -40.2% | 54,434 | -40.3% | 0.17% | -48.5% |
| Q4 2014 | $8,086,000 | +26.4% | 91,198 | +38.2% | 0.33% | +33.6% |
| Q3 2014 | $6,398,000 | +108.3% | 66,009 | +97.4% | 0.24% | +144.0% |
| Q2 2014 | $3,071,000 | +78.5% | 33,434 | -6.6% | 0.10% | +51.5% |
| Q3 2013 | $1,720,000 | +106.0% | 35,780 | +24.2% | 0.07% | +83.3% |
| Q2 2013 | $835,000 | – | 28,797 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |